Lydia Eccersley
Lydia Eccersley publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #2,685,382 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #187,226 of 367,258
- Works
- 48
- Citations
- 815
- Citations per work
- 17.0
What does Lydia Eccersley research?
Lydia Eccersley's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3062.1%
- Medicine3062.1%
- Everything else1123.2%
- Life Sciences714.7%
- 1Hematology34% of their works
- 2Molecular Biology15% of their works
- 3Genetics11% of their works
- 4Oncology8% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Pathology and Forensic Medicine4% of their works
Research topics
- Multiple Myeloma Research and Treatments
- Protein Degradation and Inhibitors
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Cancer Treatment and Pharmacology
- Cancer therapeutics and mechanisms
- Chronic Myeloid Leukemia Treatments
- HIV/AIDS drug development and treatment
Which keywords describe Lydia Eccersley's research?
The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, BET Bromodomains, PROTACs, JAK2 Mutation, Myelofibrosis, Chemotherapy-Induced Peripheral Neuropathy and Chronic Lymphocytic Leukemia.
- Topoisomerases
- HIV Infection
- BCR-ABL
- Taxanes
- Chronic Lymphocytic Leukemia
- Myelofibrosis
- PROTACs
- International Myeloma Working Group
- Diagnosis Criteria
- BET Bromodomains
- JAK2 Mutation
- Chemotherapy-Induced Peripheral Neuropathy
- Genomic Aberrations
- Antiretroviral Therapy
- DNA
- Imatinib
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Diagnosis Criteria351 topic
- International Myeloma Working Group351 topic
- BET Bromodomains121 topic
- PROTACs121 topic
- JAK2 Mutation81 topic
- Myelofibrosis81 topic
- Chemotherapy-Induced Peripheral Neuropathy41 topic
- Chronic Lymphocytic Leukemia41 topic
- Genomic Aberrations41 topic
- Taxanes41 topic
- Antiretroviral Therapy31 topic
- BCR-ABL31 topic
- DNA31 topic
- HIV Infection31 topic
- Imatinib31 topic
- Topoisomerases31 topic
Where does Lydia Eccersley work?
Lydia Eccersley's main affiliation in the publication record is Age UK, United Kingdom.
How many publications and citations does Lydia Eccersley have?
OpenAlex counts 48 works and 815 citations for Lydia Eccersley, an h-index of 9, ranking #2,685,382 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lydia Eccersley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.